FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

8246011000001106: Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21187101000001111 Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
47211201000001110 Raptiva 125mg powder and solvent for solution for injection vials (Merck Serono Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Is a Efalizumab 125mg powder and solvent for solution for injection vials true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has active ingredient Efalizumab true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Is a Raptiva true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has specific active ingredient Efalizumab true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Has manufactured dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Is pack of False Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Ltd) 4 vial Is pack of False Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Ltd) 4 vial Has AMP True Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Inferred relationship Existential restriction modifier
Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) 1 vial Has AMP True Raptiva 125mg powder and solvent for solution for injection vials (Serono Laboratories (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start